The University of Southampton
×
Filter your search:
University of Southampton Institutional Repository

The role and uses of antibodies in COVID-19 infections: a living review

The role and uses of antibodies in COVID-19 infections: a living review
The role and uses of antibodies in COVID-19 infections: a living review
Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various prophylactic and therapeutic uses of antibodies to alleviate disease in addition to the potential of cross-reactive therapies and the implications of long-term immunity.
Scourfield, D. Oliver
55d54bf5-818b-4cce-adf9-d43e0829602e
Reed, Sophie G.
1ff2b2c8-d9e0-4423-9bd4-5df2bb7374b0
Quastel, Max
0ad52505-deac-4154-a512-d9caab10b50d
Wann, Angus
f1b0ea2f-dc8a-4588-a9d8-ae462ed0a993
et al.
The Oxford-Cardiff COVID-19 Literature Consortium
Scourfield, D. Oliver
55d54bf5-818b-4cce-adf9-d43e0829602e
Reed, Sophie G.
1ff2b2c8-d9e0-4423-9bd4-5df2bb7374b0
Quastel, Max
0ad52505-deac-4154-a512-d9caab10b50d
Wann, Angus
f1b0ea2f-dc8a-4588-a9d8-ae462ed0a993

Scourfield, D. Oliver, Reed, Sophie G. and Quastel, Max , et al. and The Oxford-Cardiff COVID-19 Literature Consortium (2021) The role and uses of antibodies in COVID-19 infections: a living review. Oxford Open Immunology, 2 (1), [iqab003]. (doi:10.1093/oxfimm/iqab003).

Record type: Article

Abstract

Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various prophylactic and therapeutic uses of antibodies to alleviate disease in addition to the potential of cross-reactive therapies and the implications of long-term immunity.

Text
iqab003 - Version of Record
Available under License Creative Commons Attribution.
Download (527kB)

More information

Accepted/In Press date: 7 January 2021
Published date: 28 January 2021
Learn more about Institute for Life Sciences research

Identifiers

Local EPrints ID: 488389
URI: http://eprints.soton.ac.uk/id/eprint/488389
DOI: doi:10.1093/oxfimm/iqab003
PURE UUID: 6df5e2f9-d22b-4159-9980-0e7d30b58bfd
ORCID for Angus Wann: ORCID iD orcid.org/0000-0002-8224-8661

Catalogue record

Date deposited: 21 Mar 2024 17:37
Last modified: 23 Mar 2024 03:11

Export record

Altmetrics

Contributors

Author: D. Oliver Scourfield
Author: Sophie G. Reed
Author: Max Quastel
Author: Angus Wann ORCID iD
Corporate Author: et al.
Corporate Author: The Oxford-Cardiff COVID-19 Literature Consortium

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Library staff additional information
Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×